Letter Re: 'Sex differences in the pharmacokinetics of anticancer drugs: a systematic review'.
作者信息
Marie S, Tournier N
机构信息
Université Paris-Saclay, CEA, Inserm, CNRS, BioMaps, Service Hospitalier Frédéric Joliot, Orsay, France; Département de Pharmacie Clinique, Faculté de Pharmacie, Université Paris-Saclay, Châtenay-Malabry, France; AP-HP, Université Paris-Saclay, Hôpital Bicêtre, Pharmacie Clinique, Le Kremlin Bicêtre, France.
Université Paris-Saclay, CEA, Inserm, CNRS, BioMaps, Service Hospitalier Frédéric Joliot, Orsay, France.
出版信息
ESMO Open. 2025 May 21;10(6):105292. doi: 10.1016/j.esmoop.2025.105292.
Abstract
摘要
相似文献
1
Letter Re: 'Sex differences in the pharmacokinetics of anticancer drugs: a systematic review'.关于《抗癌药物药代动力学的性别差异：系统评价》的信函
ESMO Open. 2025 May 21;10(6):105292. doi: 10.1016/j.esmoop.2025.105292.
2
Aquatic ecotoxicology of anticancer drugs: A systematic review.抗癌药物的水生生态毒理学：系统评价。
Sci Total Environ. 2021 Dec 15;800:149598. doi: 10.1016/j.scitotenv.2021.149598. Epub 2021 Aug 11.
3
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.妊娠相关的药代动力学变化：一项系统评价。
PLoS Med. 2016 Nov 1;13(11):e1002160. doi: 10.1371/journal.pmed.1002160. eCollection 2016 Nov.
4
A systematic review of pharmacokinetics studies in children with protein-energy malnutrition.蛋白质-能量营养不良儿童的药代动力学研究系统评价。
Eur J Clin Pharmacol. 2010 Oct;66(10):1025-35. doi: 10.1007/s00228-010-0851-0. Epub 2010 Jun 16.
5
Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer.孕期妇科肿瘤中抗癌药物的使用：母体药代动力学和经胎盘转运的系统评价
Expert Opin Drug Metab Toxicol. 2016 May;12(5):523-31. doi: 10.1517/17425255.2016.1167187. Epub 2016 Apr 4.
6
Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review.血管内皮生长因子靶向治疗在免疫检查点抑制剂预处理的肾细胞癌患者中的应用：系统文献回顾。
Cancer Treat Rev. 2024 Jan;122:102652. doi: 10.1016/j.ctrv.2023.102652. Epub 2023 Nov 4.
7
The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.雷珠单抗治疗并延长方案在新生血管性年龄相关性黄斑变性中的临床疗效：系统评价与网状Meta分析
Adv Ther. 2017 Mar;34(3):611-619. doi: 10.1007/s12325-017-0484-0. Epub 2017 Feb 10.
8
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022.铂（IV）类抗肿瘤药物与抗肿瘤免疫反应在医学无机化学中的作用。2017 年至 2022 年的系统评价。
Eur J Med Chem. 2022 Dec 5;243:114680. doi: 10.1016/j.ejmech.2022.114680. Epub 2022 Sep 12.
9
Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings.抗癌药物所致心脏毒性分子靶点的见解：基于蛋白质组学研究结果的系统评价
Metabolism. 2022 Sep;134:155250. doi: 10.1016/j.metabol.2022.155250. Epub 2022 Jul 6.
10
Do sex differences in paediatric type 1 diabetes care exist? A systematic review.儿童 1 型糖尿病照护中是否存在性别差异？系统综述。
Diabetologia. 2023 Apr;66(4):618-630. doi: 10.1007/s00125-022-05866-4. Epub 2023 Jan 26.
本文引用的文献
1
Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure.成像性别和年龄对人体有机阴离子转运多肽（OATP）功能的影响：对全身药代动力学和肝脏暴露的影响。
Acta Pharm Sin B. 2025 May;15(5):2736-2745. doi: 10.1016/j.apsb.2025.03.030. Epub 2025 Mar 17.
2
Exploratory Study of Sex Differences in P-Glycoprotein Function at the Blood-Brain Barrier.血脑屏障处P-糖蛋白功能性别差异的探索性研究
Clin Transl Sci. 2025 Apr;18(4):e70196. doi: 10.1111/cts.70196.
3
Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.抗癌药物药代动力学中的性别差异：一项系统评价。
ESMO Open. 2024 Dec;9(12):104002. doi: 10.1016/j.esmoop.2024.104002. Epub 2024 Dec 10.
4
Membrane transporters in drug development and as determinants of precision medicine.药物开发中的膜转运体和精准医学的决定因素。
Nat Rev Drug Discov. 2024 Apr;23(4):255-280. doi: 10.1038/s41573-023-00877-1. Epub 2024 Jan 24.
5
Imaging techniques to study drug transporter function in vivo.用于研究体内药物转运体功能的成像技术。
Pharmacol Ther. 2018 Sep;189:104-122. doi: 10.1016/j.pharmthera.2018.04.006. Epub 2018 Apr 22.
Zotero 插件